165 related articles for article (PubMed ID: 8238015)
1. Synthesis of beta 2-microglobulin in lymphocyte culture: role of hemodialysis, dialysis membranes, dialysis-amyloidosis, and lymphokines.
Campistol JM; Molina R; Bernard DB; Rodriguez R; Mirapeix E; Munoz-Gomez JM; Revert L
Am J Kidney Dis; 1993 Nov; 22(5):691-9. PubMed ID: 8238015
[TBL] [Abstract][Full Text] [Related]
2. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
3. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
Czyz W; Szepietowski T
Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
[TBL] [Abstract][Full Text] [Related]
4. Dialysis membranes inhibit synthesis and release of beta 2-microglobulin in lymphocyte culture.
Campistol JM; Molina R; Rodriguez R; Mirapeix E; Muñoz-Gomez J; Revert L
Nephron; 1991; 59(4):691-2. PubMed ID: 1809274
[No Abstract] [Full Text] [Related]
5. Beta 2-microglobulin levels in patients with renal insufficiency.
Acchiardo S; Kraus AP; Jennings BR
Am J Kidney Dis; 1989 Jan; 13(1):70-4. PubMed ID: 2643313
[TBL] [Abstract][Full Text] [Related]
6. Suppression of beta 2-microglobulin release from lymphocytes by dialysis membranes.
Schaefer RM; Paczek L; Heidland A
Nephrol Dial Transplant; 1991; 6 Suppl 3():53-6. PubMed ID: 1775269
[TBL] [Abstract][Full Text] [Related]
7. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis?
Schwalbe S; Holzhauer M; Schaeffer J; Galanski M; Koch KM; Floege J
Kidney Int; 1997 Oct; 52(4):1077-83. PubMed ID: 9328948
[TBL] [Abstract][Full Text] [Related]
9. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
[TBL] [Abstract][Full Text] [Related]
10. [Dialysis amyloidosis and beta-2-microglobulin].
Sulková S; Votruba T
Cas Lek Cesk; 1989 Jan; 128(3):68-73. PubMed ID: 2655913
[TBL] [Abstract][Full Text] [Related]
11. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
Miyata T
Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
[TBL] [Abstract][Full Text] [Related]
12. Behavior of beta 2-microglobulin (B2-m) serum levels in uremic patients.
Mioli VA; Balestra E; Bibiano L; Dellabella S; Fanciulli E; Gaffi G; Perilli A; Petroselli F; Ricciatti AM; Carletti P
Int J Artif Organs; 1994 Nov; 17(11):576-80. PubMed ID: 7744516
[TBL] [Abstract][Full Text] [Related]
13. Circulating form of beta-2-microglobulin in dialysis patients.
Gagnon RF; Somerville P; Thomson DM
Am J Nephrol; 1988; 8(5):379-83. PubMed ID: 3071144
[TBL] [Abstract][Full Text] [Related]
14. Detection of novel beta 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition.
Ogawa H; Saito A; Oda O; Nakajima M; Chung TG
Clin Nephrol; 1988 Sep; 30(3):158-63. PubMed ID: 3052955
[TBL] [Abstract][Full Text] [Related]
15. [Significance of serum levels of beta-2-microglobulin in dialysis patients].
Baldrati L; Baldrati L; Delvecchio C; Capponcini C; Docci D; Turci F; Feletti C
Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid P component: a predictor of clinical beta 2-microglobulin amyloidosis.
Spiegel DM; Sprague SM
Am J Kidney Dis; 1992 May; 19(5):427-32. PubMed ID: 1585929
[TBL] [Abstract][Full Text] [Related]
17. [Beta 2-microglobulin and dialysis-related amyloidosis].
Gejyo F
Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
[TBL] [Abstract][Full Text] [Related]
18. Serum beta2-microglobulin and immunoglobulin levels in young hemodialysis patients.
Dixit MP; Cabansag MR; Piscitelli J; Greifer I; Silverstein DM
Pediatr Nephrol; 1999 Feb; 13(2):139-42. PubMed ID: 10229003
[TBL] [Abstract][Full Text] [Related]
19. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
Zingraff J; Beyne P; Ureña P; Uzan M; Nguyen Khoa Man ; Descamps-Latscha B; Drüeke T
Nephrol Dial Transplant; 1988; 3(3):284-90. PubMed ID: 3140102
[TBL] [Abstract][Full Text] [Related]
20. Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach.
Cianciolo G; Colí L; La Manna G; Donati G; D'Addio F; Comai G; Ricci D; Dormi A; Wratten M; Feliciangeli G; Stefoni S
Int J Artif Organs; 2007 Oct; 30(10):864-78. PubMed ID: 17992647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
